Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Marie-Line Tinel has worked on the following 6 EPO patent applications which have been published in the last five years:

EP11305902

2-amino-2-oxoethyl trans-3-[5-(6-methoxy-naphtalen-1-yl)-1,3-dioxan-2-yl]propyl-carbamate for use in the treatment of persistent cancer pain

IPC classification:
A61K 31/357, A61K 31/485, A61K 45/06, A61P 25/04
Applicant:
Sanofi, S.A.
Agent:
Marie-Line Tinel, Sanofi
Status:
APPLICATION REFUSED
EP11305903

2-amino-2-oxoethyl trans-3-[5-(6-methoxy-naphtalen-1-yl)-1,3-dioxan-2-yl]propyl-carbamate for use in the treatment of persistent cancer pain

IPC classification:
A61K 31/357, A61K 31/485, A61K 45/06, A61P 25/04
Applicant:
Sanofi, S.A.
Agent:
Marie-Line Tinel, Sanofi
Status:
APPLICATION REFUSED
EP12305479

Semuloparin for improving the survival of patients with cancer

IPC classification:
A61K 31/00, A61K 31/727, A61P 7/02, A61P 35/00
Applicant:
Aventis Pharma S.A.
Agent:
Marie-Line Tinel, Sanofi
Status:
APPLICATION REFUSED
EP13714652

AN H3 RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE

IPC classification:
A61K 31/4725, A61P 25/28
Applicant:
Sanofi, S.A.
Agent:
Marie-Line Tinel, Sanofi
Status:
PATENT GRANTED
EP13805299

PROCESS FOR PREPARING 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDO-4-PYRIDYL)-5-METHOXYPYRIDINE-2-CARBOXAMIDE

IPC classification:
C07D 213/69, C07D 401/06, C07D 401/12
Applicant:
Sanofi, S.A.
Agent:
Nony, Cabinet Nony
Agent:
Marie-Line Tinel, Sanofi
Status:
GRANT OF PATENT INTENDED
EP13796087

METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF

IPC classification:
A61K 31/4412, A61P 25/00, C07D 213/89
Applicant:
Sanofi, S.A.
Agent:
Cabinet Nony
Agent:
Marie-Line Tinel, Sanofi
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature